Search alternatives:
increase decrease » increased release (Expand Search), increased crash (Expand Search)
role decrease » rate decreased (Expand Search), road decreased (Expand Search), note decreased (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search), fold increases (Expand Search)
Showing 761 - 780 results of 14,400 for search '(( significant increase decrease ) OR ( significant ((role decrease) OR (fold decrease)) ))', query time: 0.57s Refine Results
  1. 761
    The solvent accessible surface area (SASA) of wild-type (green line) AKR1C3 (complexed with the ligand, NADPH) was lower than that of the mutant (purple line) AKR1C3 (complexed with the ligand, NADPH).

    The solvent accessible surface area (SASA) of wild-type (green line) AKR1C3 (complexed with the ligand, NADPH) was lower than that of the mutant (purple line) AKR1C3 (complexed wit... by Md. Akeruzzaman Shaon (21511929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 762
    Hardy‒Weinberg equilibrium test of rs12529 in the study subjects.

    Hardy‒Weinberg equilibrium test of rs12529 in the study subjects. by Md. Akeruzzaman Shaon (21511929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 763
    Demographic characteristics of the breast cancer patients enrolled in the study.

    Demographic characteristics of the breast cancer patients enrolled in the study. by Md. Akeruzzaman Shaon (21511929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 764
    FPRP values for the association between rs12529 and breast cancer risk.

    FPRP values for the association between rs12529 and breast cancer risk. by Md. Akeruzzaman Shaon (21511929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 765
    Root mean square fluctuations of the wild-type (green line) and mutant (H5Q) (purple line) proteins of AKR1C3 (complexed with the ligand NADPH).

    Root mean square fluctuations of the wild-type (green line) and mutant (H5Q) (purple line) proteins of AKR1C3 (complexed with the ligand NADPH). by Md. Akeruzzaman Shaon (21511929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 766
    Representative restriction enzyme-digested products on a 2% agarose gel.

    Representative restriction enzyme-digested products on a 2% agarose gel. by Md. Akeruzzaman Shaon (21511929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 767
    The radius of gyration of wild-type and mutant (H5Q) AKR1C3 (both complexed with the ligand, NADPH).

    The radius of gyration of wild-type and mutant (H5Q) AKR1C3 (both complexed with the ligand, NADPH). by Md. Akeruzzaman Shaon (21511929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 768
    Functional effects of rs12529 (H5Q) on the AKR1C3 protein.

    Functional effects of rs12529 (H5Q) on the AKR1C3 protein. by Md. Akeruzzaman Shaon (21511929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 769
    The distribution of rs12529 (C15G) genotypes among participants categorized by menopausal status.

    The distribution of rs12529 (C15G) genotypes among participants categorized by menopausal status. by Md. Akeruzzaman Shaon (21511929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 770
    Frequency distribution of rs12529 (C15G) genotypes in breast cancer patients and control subjects.

    Frequency distribution of rs12529 (C15G) genotypes in breast cancer patients and control subjects. by Md. Akeruzzaman Shaon (21511929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 771
    The clinicopathological information of the patients involved in this study.

    The clinicopathological information of the patients involved in this study. by Md. Akeruzzaman Shaon (21511929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 772
    Genotypic distribution of rs12529 in the study subjects.

    Genotypic distribution of rs12529 in the study subjects. by Md. Akeruzzaman Shaon (21511929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 773
    Distribution of rs12529 (C15G) genotypes in patients with different tumor grades.

    Distribution of rs12529 (C15G) genotypes in patients with different tumor grades. by Md. Akeruzzaman Shaon (21511929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 774
    Distribution of rs12529 (C15G) genotypes in patients with different tumor sizes.

    Distribution of rs12529 (C15G) genotypes in patients with different tumor sizes. by Md. Akeruzzaman Shaon (21511929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 775
    Scatter plot for the significant Mendelian randomization (MR) association (P < 0.05) between mediators and anti-H. pylori IgG seropositivity.

    Scatter plot for the significant Mendelian randomization (MR) association (P < 0.05) between mediators and anti-H. pylori IgG seropositivity. by Jing Wang (6206297)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 776
    Trends of incident opioid users, L-TOT users, and L-TOT discontinuers between 2009 and 2013.

    Trends of incident opioid users, L-TOT users, and L-TOT discontinuers between 2009 and 2013. by Qian Cai (112039)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 777
    The yearly numerator, denominator and rate of incident opioid users, L-TOT users and L-TOT discontinuers from 2009 to 2019.

    The yearly numerator, denominator and rate of incident opioid users, L-TOT users and L-TOT discontinuers from 2009 to 2019. by Qian Cai (112039)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 778
    Incidence rate ratios of negative binominal regression models for yearly rates of incident opioid users, L-TOT users and L-TOT discontinuers during 2009–2013 and 2015–2019.

    Incidence rate ratios of negative binominal regression models for yearly rates of incident opioid users, L-TOT users and L-TOT discontinuers during 2009–2013 and 2015–2019. by Qian Cai (112039)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 779
    Demographic, comorbidity, concurrent drug, and opioid characteristics, among L-TOT users and L-TOT discontinuers between 2009–2019.

    Demographic, comorbidity, concurrent drug, and opioid characteristics, among L-TOT users and L-TOT discontinuers between 2009–2019. by Qian Cai (112039)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 780
    <i>N. parisii</i> infection is not significantly changed in <i>C. elegans</i> sphingolipid biosynthesis mutants.

    <i>N. parisii</i> infection is not significantly changed in <i>C. elegans</i> sphingolipid biosynthesis mutants. by Hala Tamim El Jarkass (16625309)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: